MAPT and Alzheimer disease: It was demonstrated that compounds that enhance mitophagy/autophagy pathways (resveratrol, spermidine, urolithin A, NAD+) can suppress APP/Aβ-induced and mutant Tau-induced mitochondrial and synaptic dysfunctions in mouse and cell line models of AD [164].